Skip to content

Urinary pathogens

Urinary pathogens

Source of data: https://www.chp.gov.hk/en/statistics/data/10/641/697/3345.html

Year Specimens tested
2014 56,835
2015 56,586
2016 60,073
2017 62,332
2018 61,306
2019 62,215
2020 63,083
2021 75,455
2022 59,026
2023 69,286

Escherichia coli

Year Number Ampicillin Amoxicillin + clavulanic acid Nitrofurantoin Co-trimoxazole Levofloxacin# ESBL+
Resistant % Resistant % Resistant % Resistant % Resistant % Detected %
2014 5,777 3,866 66.90% 393 6.80% 109 1.90% 2,319 40.10% 1,791 31.00% 1,076 18.60%
2015 5,857 3,912 66.80% 335 5.70% 92 1.60% 2,186 37.30% 1,803 30.80% 1,042 17.80%
2016 6,117 4,065 66.50% 267 4.40% 39 0.60% 2,192 35.80% 1,984 32.40% 1,106 18.10%
2017 6,286 4,266 67.90% 353 5.60% 36 0.60% 2,170 34.50% 1,953 31.10% 1,121 17.80%
2018 6,373 4,309 67.60% 383 6.00% 55 0.90% 2,323 36.50% 1,965 30.80% 1,112 17.40%
2019 6,430 4,343 67.50% 398 6.20% 73 1.10% 2,221 34.50% 2,260 35.10% 1,180 18.40%
2020 6,444 4,134 64.20% 359 5.60% 68 1.10% 2,036 31.60% 2,218 34.40% 1,093 17.00%
2021 7,550 4,809 63.70% 426 5.60% 64 0.80% 2,287 30.30% 2,684 35.50% 1,278 16.90%
2022 6,053 3,812 62.98% 374 6.18% 65 1.07% 1,795 29.65% 2,121 35.04% 1,002 16.55%
2023 8,533 5,321 62.40% 555 6.50% 67 0.80% 2,463 28.90% 3,084 36.10% 1,121 13.10%

Klebsiella pneumoniae complex

These organisms are intrinsically resistant to ampicillin.

Year Number Amoxicillin + clavulanic acid Nitrofurantoin Co-trimoxazole Levofloxacin# ESBL+
Resistant % Resistant % Resistant % Resistant % Detected %
2014 967 87 9.00% 327 33.80% 188 19.40% 96 9.90% 87 9.00%
2015 1,021 88 8.60% 189 18.50% 198 19.40% 69 6.80% 108 10.60%
2016 1,140 98 8.60% 159 13.90% 238 20.90% 56 4.90% 114 10.00%
2017 1,064 91 8.60% 182 17.10% 192 18.00% 90 8.50% 112 10.50%
2018 1,147 85 7.40% 166 14.50% 203 17.70% 73 6.40% 104 9.10%
2019 1,149 93 8.10% 233 20.30% 197 17.10% 111 9.70% 103 9.00%
2020 1,307 109 8.30% 339 25.90% 225 17.20% 134 10.30% 94 7.20%
2021 1,429 130 9.10% 445 31.10% 233 16.30% 180 12.60% 143 10.00%
2022 1,244 82 6.59% 331 26.61% 169 13.59% 110 8.84% 134 10.77%
2023 2,118 140 6.60% 436 20.60% 247 11.70% 147 6.90% 109 5.10%

#Updated breakpoint according to CLSI document M100 29th edition was implemented from April 2019 onwards.

ESBL+: Extended spectrum beta lactamase positive

Download Urinary pathogens(in CSV format)